Disease Biology

Mechanisms of resistance in CLL and how they can be predicted 1:20
Mechanisms of resistance in CLL and how they can be predicted
Barbara Eichhorst • 6 Sep 2021
Patient segmentation for targeted therapy in myeloma 4:52
Patient segmentation for targeted therapy in myeloma
Faith Davies et al. • 11 Sep 2021
Precursor conditions: management of smoldering myeloma 6:05
Precursor conditions: management of smoldering myeloma
Irene Ghobrial et al. • 10 Sep 2021
Next steps for myeloma research and treatment 4:30
Next steps for myeloma research and treatment
Faith Davies et al. • 11 Sep 2021
Key highlights of IMW 2021 1:27
Key highlights of IMW 2021
Heinz Ludwig et al. • 9 Sep 2021
ADCs for the treatment of myeloma 3:02
ADCs for the treatment of myeloma
Katja Weisel • 10 Sep 2021
Key updates from the IMW 2021 meeting 2:59
Key updates from the IMW 2021 meeting
Noopur Raje • 11 Sep 2021
IMW highlights: the myeloma transcriptome 3:02
IMW highlights: the myeloma transcriptome
Jill Corre • 9 Sep 2021
Defining high-risk myeloma 2:49
Defining high-risk myeloma
Jill Corre • 9 Sep 2021
Artificial intelligence in myeloma 1:07
Artificial intelligence in myeloma
Jill Corre • 9 Sep 2021
The pharmacokinetics of pirtobrutinib 1:57
The pharmacokinetics of pirtobrutinib
Catherine C. Coombs • 9 Sep 2021
CCR10 as a potential target in myeloma 2:29
CCR10 as a potential target in myeloma
Arun Wiita • 2 Sep 2021
The role of MRD in AML 1:35
The role of MRD in AML
Jacqueline Cloos • 18 Aug 2021
Genetic mutations in ALL patients & implications for treatment decisions 5:14
Genetic mutations in ALL patients & implications for treatment decisions
Shawn Lee • 19 Aug 2021
Disparities in outcomes for patients with ALL 0:48
Disparities in outcomes for patients with ALL
Shawn Lee • 19 Aug 2021
Genetic ancestry: the implications for biology and prognosis of childhood ALL 3:38
Genetic ancestry: the implications for biology and prognosis of childhood ALL
Shawn Lee • 19 Aug 2021
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals